Posts

Showing posts with the label Celiac Disease market forecast

Celiac Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Celiac Disease Market Outlook Thelansis’s “Celiac Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Celiac Disease   treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Celiac Disease Overview Celiac disease is an immune-mediated disorder characterized by small intestinal enteropathy, systemic malabsorption and immune activation symptoms, and autoantibodies to tissue transglutaminase (TTG). It is unique among autoimmune diseases in that the trigger, dietary gluten, has been identified, and removing it results in the resolution of symptoms and enteropathy in most patients. The undiagnosed celiac disease might have severe cons...